We propose that in human T‐ALL, genetic alterations of LMO2 may act in a hit‐and‐run fashion in early precursors, while evolved tumor cells are reliant on alternative oncogenic mechanisms. Here, LMO2 is linked to acute lymphoblastic leukemia.